Ligne de temps
Annette Martin
Chef(fe) de Groupe
02 avr. 2024
publication
A measles-vectored vaccine candidate expressing prefusion-stabilized SARS-CoV-2 spike protein brought to phase I/II clinical trials: candidate selection in a preclinical murine model.
Lire plus01 janv. 2022
publication
Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study.
Lire plus01 sept. 2021
publication
Discovery of genes that modulate flavivirus replication in an interferon-dependent manner
Lire plus16 déc. 2020
publication
Intranasal vaccination with a lentiviral vector protects against SARS-CoV-2 in preclinical animal models.
Lire plus10 avr. 2020
19 janv. 2020
25 juil. 2018
publication
Differential regulation of the Wnt/β-catenin pathway by hepatitis C virus recombinants expressing core from various genotypes
Lire plus18 juil. 2018
publication
Immature particles and capsid-free viral RNA produced by Yellow fever virus-infected cells stimulate plasmacytoid dendritic cells to secrete interferons.
Lire plus07 févr. 2018
publication
NS2 proteases from hepatitis C virus and related hepaciviruses share composite active sites and previously unrecognized intrinsic proteolytic activities
Lire plus23 sept. 2015
publication
Determinants Involved in Hepatitis C Virus and GB Virus B Primate Host Restriction.
Lire plus29 août 2015
publication
Functional expression, purification, characterization, and membrane reconstitution of non-structural protein 2 from hepatitis C virus
Lire plus16 juil. 2015
16 avr. 2014
publication
NS2 proteins of GB virus B and hepatitis C virus share common protease activities and membrane topologies
Lire plus11 août 2010
publication
A comparative analysis of the substrate permissiveness of HCV and GBV-B NS3/4A proteases reveals genetic evidence for an interaction with NS4B protein during genome replication
Lire plus27 mai 2009
publication
Lack of adaptation of chimeric GB virus B/hepatitis C virus in the marmoset model: possible effects of bottleneck
Lire plus10 févr. 2009
publication
A cooperative interaction between nontranslated RNA sequences and NS5A protein promotes in vivo fitness of a chimeric hepatitis C/GB virus B
Lire plus01 août 2008
publication
A comparative cell biological analysis reveals only limited functional homology between the NS5A proteins of hepatitis C virus and GB virus B
Lire plus15 mai 2007
publication
Inhibition of hepatitis C virus infection in cell culture by small interfering RNAs
Lire plus06 déc. 2006
publication
Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane
Lire plus08 nov. 2006
publication
GB virus B disrupts RIG-I signaling by NS3/4A-mediated cleavage of the adaptor protein MAVS
Lire plus01 août 2006
publication
Signal peptide peptidase cleavage of GB virus B core protein is required for productive infection in vivo
Lire plus01 févr. 2006
01 mai 2005
publication
A chimeric GB virus B with 5′ nontranslated RNA sequence from hepatitis C virus causes hepatitis in tamarins
Lire plus01 avr. 2004
publication
Characterization of GB virus B polyprotein processing reveals the existence of a novel 13-kDa protein with partial homology to hepatitis C virus p7 protein
Lire plus07 août 2003
publication
Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA
Lire plus01 août 2002
publication
Analysis of deletion mutants indicates that the 2A polypeptide of hepatitis A virus participates in virion morphogenesis
Lire plus01 févr. 2001
publication